Hyperbaric Oxygen Therapy (HBOT) is gaining attention as a potential supportive treatment for breast cancer patients. HBOT addresses tumors metabolically, overcoming tumor hypoxia, which is considered one of the hallmarks of cancer treatment resistance. Even when isolated, HBOT appears to interfere with tumor growth, metastases, angiogenesis, and stimulates anticancer gene expression.
HBOT has also been shown to improve the effectiveness of certain chemotherapy drugs by enhancing their delivery to tumor cells. A radioenhancer, it sensitizes cells to radiation, increasing the effectiveness of radiation therapy. Moreover, HBOT significantly improves the quality of life for patients by alleviating common treatment-related side effects such as fatigue, nausea, loss of appetite, and cognitive issues like brain fog.
Another key benefit of HBOT for breast cancer patients is its ability to support wound healing after surgery. Many breast cancer patients undergo mastectomy or lumpectomy, and some may experience complications with healing due to radiation or compromised immune systems. Studies suggest that HBOT can reduce the risk of infection and promote faster recovery by increasing the concentration of oxygen in the blood, allowing the body to repair tissues more efficiently. This is particularly beneficial for those undergoing radiation therapy, as the treatment can cause damage to healthy tissues around the cancer site. HBOT helps improve blood flow and oxygenation in those areas, which can speed up recovery and reduce side effects such as radiation burns, chronic pain, and fatigue.
Additional studies provide strong evidence for the role of HBOT in cancer care. One study published in the National Center for Biotechnology Information (NCBI) highlights the effectiveness of HBOT in promoting tumor retraction and mitigating aggressive tumor behavior NCBI Study. Another study from the Bergen Open Research Archive explores how HBOT aids in overall recovery by improving the therapeutic response to cancer treatments like radiation Bergen Open Research Archive.
In conclusion, Hyperbaric Oxygen Therapy (HBOT) offers promising support for breast cancer patients as they navigate treatment and recovery. By improving oxygen delivery to tumor sites and enhancing the effectiveness of chemotherapy and radiation, HBOT can play a key role in overcoming cancer treatment resistance. Beyond its anti-tumor benefits, HBOT is valued for its impact on patients’ overall well-being, helping alleviate fatigue, nausea, cognitive issues, and surgical healing complications. As research progresses, HBOT continues to show great potential as an adjunct therapy, offering a multi-faceted approach to improve both the effectiveness of traditional treatments and quality of life for breast cancer patients.
The post Breast Cancer and HBOT first appeared on Hyperbaric Vermont.
The post Breast Cancer and HBOT appeared first on Hyperbaric Vermont.